Join the Cialis group to help and get support from people like you.
Cialis News
Viagra, Cialis May Help Reduce Alzheimer's Risk
THURSDAY, Feb. 8, 2023 – Could drugs that give a boost to men's sexual performance help them stave off Alzheimer's disease? That's the main finding from a study suggesting that erectile dysfunction...
Viagra, Cialis Plus a Heart Med Could Be a Dangerous Combo
MONDAY, Jan. 15, 2024 – Taking nitrates for heart problems alongside erectile dysfunction drugs like Viagra or Cialis could be a prescription for trouble, a new study warns. Men who combine the two...
FDA Medwatch Alert: Dietary Supplements for Male Sexual Enhancement by A and H Focal: Recall - Undeclared Drug Ingredient
[Posted 03/07/2017] ISSUE: A&H Focal Inc. is voluntarily recalling all lots marketed as dietary supplements for male sexual enhancement from January 2014 to present. These products have been...
FDA Medwatch Alert: SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug Ingredient
ISSUE: BeaMonstar Products notified the public that it is recalling its SexVoltz, Velextra, and Amerect capsules to the retail level. Laboratory analysis conducted by the FDA on SexVoltz and Velextra...
FDA Medwatch Alert: Bullet Proof: Public Notification - Undeclared Drug Ingredient
ISSUE: FDA is advising consumers not to purchase or use “Bullet Proof,” a product promoted and sold for sexual enhancement on various websites and in some retail stores. FDA laboratory analysis con...
FDA Medwatch Alert: American Lifestyle Vicerex and Black Ant Capsules: Recall - Undeclared Drug Ingredient
ISSUE: May 1, 2013 - American Lifestyle is announcing that it is conducting a voluntary recall of all lots of Vicerex UPC 893490820087 and Black Ant UPC 4026666142546. Laboratory analysis conducted...
FDA Medwatch Alert: Mojo Nights and Mojo Nights for Her: Recall - Undeclared Drug Ingredient
ISSUE: Evol Nutrition Associates, Inc./Red Dawn (“Evol Nutrition”) notified the public of a nationwide recall of all lots of two dietary supplement products distributed by the company under the names ...
FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
October 6, 2011 – The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate...
FDA Medwatch Alert: Cialis (Tadalafil) - Jul 8, 2005
[Posted 07/08/2005] FDA notified healthcare professionals of updated labeling for Cialis, Levitra and Viagra to reflect a small number of post-marketing reports of sudden vision loss, attributed to...
FDA Medwatch Alert: Cialis (tadalafil) - Oct 18, 2007
[Posted 10/18/2007] FDA informed healthcare professionals of reports of sudden decreases or loss of hearing following the use of PDE5 inhibitors Viagra, Levitra, Cialis for the treatment of erectile...
Further information
Related condition support groups
Erectile Dysfunction, Benign Prostatic Hyperplasia (BPH)